Diphenylbutylpiperidine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Base chemical structure of the diphenylbutylpiperidine antipsychotics.

Diphenylbutylpiperidines are a class of typical antipsychotic drugs which were all synthesized, developed, and marketed by Janssen Pharmaceutica.[1][2]

They include:

Amperozide is an atypical antipsychotic of the diphenylbutylpiperazine class.

See also[edit]

References[edit]

  1. ^ Galizzi JP, Fosset M, Romey G, Laduron P, Lazdunski M (October 1986). "Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors". Proceedings of the National Academy of Sciences of the United States of America 83 (19): 7513–7. doi:10.1073/pnas.83.19.7513. PMC 386749. PMID 2429309. 
  2. ^ Qar J, Galizzi JP, Fosset M, Lazdunski M (September 1987). "Receptors for diphenylbutylpiperidine neuroleptics in brain, cardiac, and smooth muscle membranes. Relationship with receptors for 1,4-dihydropyridines and phenylalkylamines and with Ca2+ channel blockade". European Journal of Pharmacology 141 (2): 261–8. doi:10.1016/0014-2999(87)90271-8. PMID 2445589.